Search clinical trials for: carfilzomib
Total 227 results
-
Ajai ChariAmgenCompletedRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.TerminatedLymphomaUnited States
-
University of ArkansasOnyx Therapeutics, Inc.No longer available
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.Completed
-
AmgenCompleted
-
AmgenCompletedMultiple MyelomaUnited States, Canada
-
Thomas LundRecruiting
-
Washington University School of MedicineCompleted
-
NovartisAmgenTerminated
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Christian BuskeAmgen; Janssen, LPRecruitingWaldenstrom MacroglobulinemiaAustria, Germany, Greece
-
AmgenMultiple Myeloma Research FoundationApproved for marketing
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
University of NebraskaNational Cancer Institute (NCI); AmgenCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/LymphomaUnited States
-
AmgenCompletedRenal Insufficiency | Multiple MyelomaUnited States
-
SCRI Development Innovations, LLCAmgenCompletedNeuroendocrine CancerUnited States
-
John F. McDyer, MDCompletedLung Transplant RejectionUnited States
-
AmgenCompletedMultiple Myeloma | Solid TumorsUnited States, Canada
-
Spectrum Health HospitalsCompletedMultiple MyelomaUnited States
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
OncotherapeuticsAmgenCompletedMultiple MyelomaUnited States
-
Sheba Medical CenterUnknown
-
Peking University First HospitalRecruitingMultiple Myeloma | Renal InjuryChina
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMultiple MyelomaUnited States
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusCompletedMultiple MyelomaGermany, Italy
-
iOMEDICO AGAmgenActive, not recruiting
-
Ohio State University Comprehensive Cancer CenterAmgenCompletedHematopoietic/Lymphoid Cancer | Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
University of BirminghamCelgene; Amgen; BloodwiseCompletedPeripheral T Cell LymphomaUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
PfizerRecruiting
-
E. Steve WoodleAmgenUnknown
-
AmgenCompletedMultiple MyelomaFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
Northwestern UniversityAmgenTerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary Syndrome | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IA Mycosis Fungoides/Sezary Syndrome | Stage... and other conditionsUnited States
-
University of RochesterMassey Cancer CenterCompleted
-
AmgenCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Non-Secretory Plasma Cell Myeloma | PlasmacytosisUnited States
-
SCRI Development Innovations, LLCNovartis; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Cancer Research and Biostatistics Clinical Trials...Washington University School of Medicine; Lucille P. Markey Cancer Center at...UnknownSmall Cell Lung Carcinoma | Non Small Cell Lung Carcinoma | Irinotecan Sensitive CancersUnited States
-
University of Michigan Rogel Cancer CenterCompletedHematologic Malignancies | Graft-Versus-Host Disease | RelapseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
AmgenCompleted
-
University of Alabama at BirminghamAmgenCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedMultiple Myeloma | Leukemia, Plasma CellUnited States
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands